DK3138556T3 - Fremgangsmåde til fremstilling af liposomer - Google Patents
Fremgangsmåde til fremstilling af liposomer Download PDFInfo
- Publication number
- DK3138556T3 DK3138556T3 DK15785778.0T DK15785778T DK3138556T3 DK 3138556 T3 DK3138556 T3 DK 3138556T3 DK 15785778 T DK15785778 T DK 15785778T DK 3138556 T3 DK3138556 T3 DK 3138556T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparing liposomes
- liposomes
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
- B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014094142 | 2014-04-30 | ||
PCT/JP2015/062985 WO2015166988A1 (ja) | 2014-04-30 | 2015-04-30 | リポソームの製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3138556T3 true DK3138556T3 (da) | 2022-04-11 |
Family
ID=54358712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15785778.0T DK3138556T3 (da) | 2014-04-30 | 2015-04-30 | Fremgangsmåde til fremstilling af liposomer |
Country Status (7)
Country | Link |
---|---|
US (1) | US10117833B2 (da) |
EP (1) | EP3138556B1 (da) |
JP (1) | JP6155387B2 (da) |
DK (1) | DK3138556T3 (da) |
ES (1) | ES2909245T3 (da) |
PL (1) | PL3138556T3 (da) |
WO (1) | WO2015166988A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3138555T3 (pl) | 2014-04-30 | 2021-04-06 | Fujifilm Corporation | Kompozycja liposomowa i sposób jej wytwarzania |
JP6564873B2 (ja) * | 2015-11-02 | 2019-08-21 | 富士フイルム株式会社 | リポソーム組成物およびその製造方法 |
CA3173715A1 (en) | 2020-04-03 | 2021-10-07 | Takeshi Matsumoto | Anti-tumor agent comprising a liposome encompassing gemcitabine,and usesthereof |
CN113456593A (zh) * | 2021-06-30 | 2021-10-01 | 花安堂生物科技集团有限公司 | 一种脂质体乳液的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4588578A (en) | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
FR2608942B1 (fr) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules |
FR2634375B3 (fr) | 1988-06-30 | 1991-07-05 | Centre Nat Rech Scient | Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques |
US5174930A (en) | 1986-12-31 | 1992-12-29 | Centre National De La Recherche Scientifique (Cnrs) | Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions |
ATE98866T1 (de) | 1989-10-12 | 1994-01-15 | Oreal | Verfahren zur herstellung einer waessrigen dispersion von lipidvesikeln sowie zusammensetzung auf basis der so hergestellten dispersion. |
FR2653015B1 (fr) | 1989-10-12 | 1993-10-29 | Oreal | Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant. |
GB9717476D0 (en) * | 1997-08-18 | 1997-10-22 | Nycomed Imaging As | Process |
PT937456E (pt) * | 1998-02-23 | 2004-10-29 | Cilag Ag Int | Dispersao lipossomal de eritropoietina |
JP2003255912A (ja) * | 2002-03-05 | 2003-09-10 | Seiko Epson Corp | 電気光学装置、それを用いた電子機器および電気光学装置の駆動方法 |
WO2006126244A1 (ja) * | 2005-05-23 | 2006-11-30 | Mebiopharm Co., Ltd. | ガス封入リポソームの製造法 |
WO2011062255A1 (ja) | 2009-11-20 | 2011-05-26 | コニカミノルタホールディングス株式会社 | 混合有機溶媒を油相として用いる二段階乳化によるリポソームの製造方法 |
WO2011062132A1 (ja) * | 2009-11-20 | 2011-05-26 | コニカミノルタホールディングス株式会社 | W/o/wエマルションの製造方法およびこれを用いたリポソームの製造方法、並びにこれらの方法に用いられる孔膜 |
JP6207007B2 (ja) * | 2012-05-15 | 2017-10-04 | 国立大学法人 千葉大学 | リポソームおよびその作製方法 |
-
2015
- 2015-04-30 EP EP15785778.0A patent/EP3138556B1/en active Active
- 2015-04-30 ES ES15785778T patent/ES2909245T3/es active Active
- 2015-04-30 WO PCT/JP2015/062985 patent/WO2015166988A1/ja active Application Filing
- 2015-04-30 JP JP2016516408A patent/JP6155387B2/ja active Active
- 2015-04-30 PL PL15785778T patent/PL3138556T3/pl unknown
- 2015-04-30 DK DK15785778.0T patent/DK3138556T3/da active
-
2016
- 2016-10-27 US US15/336,131 patent/US10117833B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3138556B1 (en) | 2022-03-02 |
JP6155387B2 (ja) | 2017-06-28 |
EP3138556A1 (en) | 2017-03-08 |
WO2015166988A1 (ja) | 2015-11-05 |
EP3138556A4 (en) | 2017-03-08 |
JPWO2015166988A1 (ja) | 2017-04-20 |
ES2909245T3 (es) | 2022-05-06 |
PL3138556T3 (pl) | 2022-05-16 |
US10117833B2 (en) | 2018-11-06 |
US20170042812A1 (en) | 2017-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
DK3192902T3 (da) | Fremgangsmåde til fremstilling af graphenholdige viscosefibre | |
DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
DK3096741T3 (da) | Fremgangsmåde til fremstillingen af hybridosomer | |
DK3294885T3 (da) | Fremgangsmåde til at fremstille rna | |
DK3180331T3 (da) | Polymorfer af selinexor | |
DK3174858T3 (da) | Fremgangsmåde til fremstilling af pyrazoler | |
DK3294700T3 (da) | Fremgangsmåde til fremstilling af limonen-4-ol | |
DK3122444T3 (da) | Fremgangsmåde til fremstilling af membraner | |
DK3473621T3 (da) | Fremgangsmåde til fremstilling af diphenylmethan-derivat | |
IL259085A (en) | A method for preparing membranes | |
DK3515990T3 (da) | Fremgangsmåde til fremstilling af lignocellulosematerialer | |
DK3010352T3 (da) | Fremgangsmåde til fremstilling af fodertilsætning | |
DK3134084T3 (da) | Fremgangsmåde til behandling af lungeadenokarcinom | |
DK3166904T3 (da) | Fremgangsmåde til fremstilling af betonelementer | |
DK3166927T3 (da) | Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxy-picolinsyre | |
DK3174988T3 (da) | Fremgangsmåde til fremstilling af mælkesyre | |
DK3191498T3 (da) | Fremgangsmåde til fremstilling af 2'-o-fucosyllactose | |
DK3233813T3 (da) | Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser | |
DK3137449T3 (da) | Fremgangsmåder til fremstilling af substituerede cycloseriner | |
DK3418273T3 (da) | Derivater af flavagliner | |
DK3295941T3 (da) | Fremgangsmåde til fremstilling af form a af grapiprant | |
DK3633103T3 (da) | Fremgangsmåde til fremstilling af et slibemiddel | |
DK3114053T3 (da) | Maskine til separation af elementer | |
DK3386947T3 (da) | Fremgangsmåde til fremstilling af n-retinoylaminoalkansulfonsyre |